IonCure

Delhi, India Founded: 2019 • Age: 7 yrs
Computational therapies for epilepsy are developed using AI by IonCure.
Annual revenue $6,084 Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors - Known backers
Products - Services tracked
Competitors 10 Brand Intelligence

About IonCure

IonCure is a company based in Delhi (India) founded in 2019 by Sukant Khurana. IonCure operates in a competitive market with competitors including Jazz Pharmaceuticals, Biogen, Neurocrine, PTC Therapeutics and Biohaven Pharmaceutical, among others.

  • Headquarter Delhi, India
  • Founders Sukant Khurana
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Ioncure Tech Private Limited
  • Date of Incorporation 20 Feb, 2020
  • Jurisdiction New Delhi, Delhi, India
Operational Areas
Healthcare → Healthcare Products & Supplies Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $6.08 K (USD)
    0
    as on Mar 31, 2021
  • Net Profit
    $705.72 (USD)
    103
    as on Mar 31, 2021
  • EBITDA
    $953.67 (USD)
    104
    as on Mar 31, 2021
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of IonCure

Premium access

Detailed funding history for IonCure

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by IonCure

Investments
Premium access

Investment portfolio details for IonCure

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - IonCure

Premium access

Detailed financials for IonCure

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Ioncure Comparisons

IonCure Primary company
Description
Computational therapies for epilepsy are developed using AI ...
Location
Delhi, India
Founded Year
2019
Annual Revenue
$6.08 K (USD)
Net Profit
$705.72 (USD)
EBITDA
$953.67 (USD)
Employees
Not available
Premium access

Peer comparison for IonCure

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of IonCure

IonCure operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Jazz Pharmaceuticals, Biogen, Neurocrine, PTC Therapeutics and Biohaven Pharmaceutical, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Novel biopharmaceutical medicines are developed for unmet medical needs.
Locked Locked Locked
Therapies for neurodegenerative and immunology disorders are developed.
Locked Locked Locked
Developer of small molecule therapeutics for endocrine and CNS disorders
Locked Locked Locked
Small molecule drugs for rare diseases are developed.
Locked Locked Locked
Therapies for neurological and neuropsychiatric diseases are developed.
Locked Locked Locked
Genetically engineered cell therapies are developed for multiple disorders.
Premium access

Detailed competitors of IonCure

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Ioncure

Premium access

Complete news archive for IonCure

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about IonCure

IonCure was founded in 2019.

IonCure is headquartered in Delhi, India. It is registered at Delhi, Delhi, India.

Sukant Khurana is the current CEO of IonCure. They have also founded this company.

Annual revenue of IonCure is $6.08K as on Mar 31, 2021.

IonCure was established in 2019 in Delhi, India, within the biotechnology sector. Computational approaches are utilized by the company to design novel molecules aimed at addressing epilepsy, Parkinsons disease, Alzheimers, diabetes, and various infectious conditions. An AI platform supports these efforts, focusing on treatment and management strategies for neurological and metabolic disorders. Operations center on research and development of targeted therapies.

IonCure's top competitors include Jazz Pharmaceuticals, PTC Therapeutics and Neurocrine.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available